Product
Yuxi Walvax MPV ACYW Vaccine
1 clinical trial
1 indication
Indication
Neisseria Meningitidis MeningitisClinical trial
A Phase IV Randomized, Observer-blind, Controlled Study to Demonstrate Non-inferior Immunogenicity of Yuxi Walvax MPV ACYW® Vaccine as Compared to Sanofi Pasteur Menactra® Vaccine in Healthy Subjects Aged 2-10 YearsStatus: Completed, Estimated PCD: 2021-07-30